Which evaluations comprise the typical pre-procedure assessment for EP ablation?

• A. Clinical history, ECG, transthoracic echocardiogram, renal function, coagulation profile, baseline labs, and imaging as needed; assessment of anticoagulation.
• B. Only imaging studies.
• C. Genetic testing and metabolic panel.
• D. No pre-procedure assessment is required.

Answer: (A)

Before EP ablation, the main goal is to identify factors that influence safety and success by evaluating the patient’s rhythm history, cardiac structure, and overall physiologic status. A thorough clinical history and ECG establish the current rhythm, prior ablations, and comorbidities that may affect the procedure. A transthoracic echocardiogram provides essential information on left ventricular function, valvular disease, and atrial size, all of which shape the ablation strategy and help anticipate risks such as thromboembolism or impaired hemodynamics. Renal function is checked because contrast agents and certain peri-procedural medications rely on kidney clearance, and it helps determine appropriate contrast dosing and hydration. A coagulation profile is crucial to gauge bleeding risk and to guide periprocedural anticoagulation management, ensuring safe vascular access and minimizing thromboembolic complications. Baseline labs, including complete blood count and electrolytes, detect anemia and disturbances (like potassium or magnesium abnormalities) that can provoke arrhythmias or affect conduction during the procedure. Additional imaging is performed as needed to delineate anatomy relevant to the ablation approach, such as left atrial or venous anatomy. Finally, a clear plan for anticoagulation around the procedure is implemented—continuing or adjusting warfarin or DOACs as indicated, and coordinating any bridging if needed—to balance bleeding and thrombotic risks.